APA (7th ed.) Citation

Yunivita, V., Maharani, A. J., Bernadus, C. A., Sinaga, E. I. J., & Simanjuntak, E. R. (2026). Maternal, Fetal, and Neonatal Outcomes of Additional Dihydroartemisinin-Piperaquine to Trimethoprim-Sulfamethoxazole in Intermittent Preventive Treatment for Malaria in HIV-Positive Pregnancies: A Systematic Review and Meta-Analysis. Therapeutics & Clinical Risk Management, 22, 1. https://doi.org/10.2147/TCRM.S571864

Chicago Style (17th ed.) Citation

Yunivita, Vycke, Amanda Jessie Maharani, Cheryl Antoinette Bernadus, Eva Ianty Julwana Sinaga, and Evita Rahel Simanjuntak. "Maternal, Fetal, and Neonatal Outcomes of Additional Dihydroartemisinin-Piperaquine to Trimethoprim-Sulfamethoxazole in Intermittent Preventive Treatment for Malaria in HIV-Positive Pregnancies: A Systematic Review and Meta-Analysis." Therapeutics & Clinical Risk Management 22 (2026): 1. https://doi.org/10.2147/TCRM.S571864.

MLA (9th ed.) Citation

Yunivita, Vycke, et al. "Maternal, Fetal, and Neonatal Outcomes of Additional Dihydroartemisinin-Piperaquine to Trimethoprim-Sulfamethoxazole in Intermittent Preventive Treatment for Malaria in HIV-Positive Pregnancies: A Systematic Review and Meta-Analysis." Therapeutics & Clinical Risk Management, vol. 22, 2026, p. 1, https://doi.org/10.2147/TCRM.S571864.